These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38040526)

  • 21. Sleep apnea and cardiovascular complications of the acromegaly. Response to the medical treatment.
    García-Álvarez M; Climent V
    Minerva Endocrinol; 2019 Jun; 44(2):159-168. PubMed ID: 30482010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acromegalic cardiomyopathy: a review of the literature.
    Matta MP; Caron P
    Pituitary; 2003; 6(4):203-7. PubMed ID: 15237931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac abnormalities in acromegaly. Pathophysiology and implications for management.
    Vitale G; Pivonello R; Lombardi G; Colao A
    Treat Endocrinol; 2004; 3(5):309-18. PubMed ID: 15330678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
    Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
    Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly.
    Clemmons DR; Bidlingmaier M
    Front Endocrinol (Lausanne); 2023; 14():1266339. PubMed ID: 38027199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular Disease in Acromegaly.
    Sharma MD; Nguyen AV; Brown S; Robbins RJ
    Methodist Debakey Cardiovasc J; 2017; 13(2):64-67. PubMed ID: 28740584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cardiovascular system in growth hormone excess and growth hormone deficiency.
    Lombardi G; Di Somma C; Grasso LF; Savanelli MC; Colao A; Pivonello R
    J Endocrinol Invest; 2012 Dec; 35(11):1021-9. PubMed ID: 23143695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heart failure as a manifestation of acromegaly].
    Ságová I; Dragula M; Kantárová D; Vaňuga A; Vaňuga P
    Vnitr Lek; 2020; 66(4):82-86. PubMed ID: 32972190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiological aspects of growth hormone and insulin-like growth factor-I.
    Lombardi G; Colao A; Cuocolo A; Longobardi S; Di Somma C; Orio F; Merola B; Nicolai E; Salvatore M
    J Pediatr Endocrinol Metab; 1997; 10(6):553-60. PubMed ID: 9467124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of juvenile acromegaly that was initially diagnosed as severe congestive heart failure from acromegaly-induced dilated cardiomyopathy.
    Sue M; Yoshihara A; Okubo Y; Ishikawa M; Ando Y; Hiroi N; Shibuya K; Yoshino G
    Intern Med; 2010; 49(19):2117-21. PubMed ID: 20930439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis and prevalence of hypertension in acromegaly.
    Bondanelli M; Ambrosio MR; degli Uberti EC
    Pituitary; 2001 Sep; 4(4):239-49. PubMed ID: 12501974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly.
    Niculescu D; Purice M; Coculescu M
    Pituitary; 2013 Jun; 16(2):168-74. PubMed ID: 22562529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency.
    Skjaerbaek C; Frystyk J; Kaal A; Laursen T; Møller J; Weeke J; Jørgensen JO; Sandahl Christiansen J; Orskov H
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):25-33. PubMed ID: 10651750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular complications of acromegaly.
    Kamenický P; Maione L; Chanson P
    Ann Endocrinol (Paris); 2021 Jun; 82(3-4):206-209. PubMed ID: 33168155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acromegalic cardiomyopathy: a neglected cause of cardiomyopathy.
    Bonora T; Rigamonti E; Capoferri M; De Perna ML
    Clin Ter; 2022 Feb; 173(1):31-34. PubMed ID: 35147643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acromegalic cardiomyopathy: Epidemiology, diagnosis, and management.
    Sharma AN; Tan M; Amsterdam EA; Singh GD
    Clin Cardiol; 2018 Mar; 41(3):419-425. PubMed ID: 29574794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly.
    Colao A; Marzullo P; Ferone D; Spinelli L; Cuocolo A; Bonaduce D; Salvatore M; Boerlin V; Lancranjan I; Lombardi G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3132-40. PubMed ID: 10999798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acromegalic Cardiomyopathy: An Overview of Risk Factors, Clinical Manifestations, and Therapeutic Options.
    Goldberg MD; Vadera N; Yandrapalli S; Frishman WH
    Cardiol Rev; 2018; 26(6):307-311. PubMed ID: 29794808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.